Millennium Pharmaceuticals Inc
- SEC CIK
- 0001002637
No open-market purchases or sales filed in the past year.
Current role at each company
- DAWN Day One Biopharmaceuticals, Inc.10% Owneras of Dec 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Millennium Pharmaceuticals Inc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 (view filing)6:04 AM ET | Dec 7-8 | 2 days | Millennium Pharmaceuticals Inc and 3 others10% Owner | SSale | −297.3K | $18.49 | −$5.50M | −4.6%6.12M after | 3 lots |
| Dec 7, 2021 (view filing)6:01 AM ET | Dec 3-6 | 4 days | Millennium Pharmaceuticals Inc and 3 others10% Owner | SSale | −110.2K | $18.10 | −$1.99M | −1.7%6.42M after | 2 lots |